ArticleBMC gastroenterology2025
Routine psychological problems screening in hospitalized inflammatory bowel diseases and its effect for progression-free survival from disease worsening.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo examine the progression-free survival from disease worsening after the implementation of routine screening for psychological problems in hospitalized patients with inflammatory bowel diseases (IBDs) during a long-term follow-up.
methodsThe retrospective cohort study enrolled 1265 patients with active IBDs. Their records were stratified into screening cohort (n = 827), receiving screening for psychological problems within 48 h after admission, and a 2:1 propensity score matching was utilized to match cases without screening as controls (n = 438). Primary endpoint was the progression-free survival from disease worsening defined as any IBDs-related emergency room visit, hospitalization or surgery during 12 months post-discharge. Secondary outcomes included quality of life (QoL) using quality-adjusted life years (QALYs) and adverse events.
resultsThe rate of progression-free survival from IBDs worsening was observed in 73.2% of patients in screening cohort, while 53.4% of cases in control cohort (odds ratio (OR) = 2.376 (95%CI: 1.864, 3.028), p < 0.001). Compared with controls, cases in screening cohort showed a superior mean of progression-free survival (log-rank p < 0.001) and a greater QALYs during the 12-month follow-up (p < 0.001). Patients in screening cohort were more likely to have hospital-acquired venous thromboembolism and pneumonia due to a longer hospital stay. No severe adverse events were observed.
conclusionsThere was evidence that patients in screening cohort had a better progression-free survival from IBDs worsening than those without these conditions, and also exhibited a better QoL during 12-month follow-up. It should be encouraged that hospitalized IBDs in active phase should be routinely screened for psychological problems that could influence disease course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.